HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study.

AbstractINTRODUCTION:
Few studies have evaluated exercise interventions for smokers with depression or other psychiatric comorbidities. This pilot study evaluated the potential role of supervised vigorous exercise as a smoking cessation intervention for depressed females.
METHODS:
Thirty adult women with moderate-severe depressive symptoms were enrolled and randomly assigned to 12 weeks of thrice weekly, in person sessions of vigorous intensity supervised exercise at a YMCA setting (EX; n = 15) or health education (HE; n = 15). All participants received behavioral smoking cessation counseling and nicotine patch therapy. Assessments were done in person at baseline, at the end of 12 weeks of treatment, and at 6 months post-target quit date. Primary end points were exercise adherence (proportion of 36 sessions attended) and biochemically confirmed 7-day point prevalence abstinence at Week 12. Biomarkers of inflammation were explored for differences between treatment groups and between women who smoked and those abstinent at Week 12.
RESULTS:
Treatment adherence was high for both groups (72% for EX and 66% for HE; p = .55). The Week 12 smoking abstinence rate was higher for EX than HE (11/15 [73%] vs. 5/15 [33%]; p = .028), but no significant differences emerged at 6-month follow-up. Interleukin-6 levels increased more for those smoking than women abstinent at Week 12 (p = .040).
CONCLUSIONS:
Vigorous intensity supervised exercise is feasible and enhances short-term smoking cessation among depressed female smokers. Innovative and cost-effective strategies to bolster long-term exercise adherence and smoking cessation need evaluation in this population. Inflammatory biomarkers could be examined in future research as mediators of treatment efficacy.
IMPLICATIONS:
This preliminary study found that vigorous intensity supervised exercise is feasible and enhances short-term smoking cessation among depressed female smokers. This research addressed an important gap in the field. Despite decades of research examining exercise interventions for smoking cessation, few studies were done among depressed smokers or those with comorbid psychiatric disorders. A novel finding was increases in levels of a pro-inflammatory biomarker observed among women who smoked at the end of the intervention compared to those who did not.
AuthorsChristi A Patten, Carrie A Bronars, Kristin S Vickers Douglas, Michael H Ussher, James A Levine, Susannah J Tye, Christine A Hughes, Tabetha A Brockman, Paul A Decker, Ramona S DeJesus, Mark D Williams, Thomas P Olson, Matthew M Clark, Angela M Dieterich
JournalNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (Nicotine Tob Res) Vol. 19 Issue 1 Pg. 77-86 (01 2017) ISSN: 1469-994X [Electronic] England
PMID27613946 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© The Author 2016. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: [email protected].
Topics
  • Adolescent
  • Adult
  • Combined Modality Therapy
  • Cost-Benefit Analysis
  • Counseling
  • Depression (psychology)
  • Diagnosis, Dual (Psychiatry)
  • Exercise Therapy (methods)
  • Feasibility Studies
  • Female
  • Humans
  • Middle Aged
  • Patient Compliance
  • Pilot Projects
  • Smoking (psychology)
  • Smoking Cessation (methods, psychology)
  • Smoking Prevention
  • Tobacco Use Cessation Devices
  • Tobacco Use Disorder (psychology, rehabilitation)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: